Title: Effects of urinary kallidinogenase combined with batroxobin on acute cerebral infarction patients
Abstract: Objective To study the effects and adverse reactions of urinary kallidinogenase (UK)combined with batroxobin on acute cerebral infarction. Methods The 96 patients with acute cer-ebral infarction were randomly divided into urinary kallidinogenase group and control group,with 48 pa-tients in each group. The patients in control group were given conventional treatment and batroxobin (10U,5U)every two days,and the patients in treatment group were additionly given UK(0. 15 PNA) added to saline solution 100 ml for intravenous drip,for 14 days. Effects were judged according to the National Institutes of Health stroke scale(NIHSS). Changes of neural function were studied. Results The total effective rate of urinary kallidinogenase group was 89. 58% . The total effective rate of control group was 77. 08%. The total effective rate of urinary kallidinogenase group was significantly higher than that of control group after 14 days of treatment. There was significant difference between the two groups (P 〈 0. 05). There were no adverse reactions in the two groups. Conclusions Urinary kallidinogenase combined with batroxobin is effective and safe in treatment of the patients with acute cerebral infarction, so it is worthy to be popularized in clinics.
Key words:
Urinary Kallidinogenase; Batroxobin; Progressive cerebral infarction
Publication Year: 2014
Publication Date: 2014-06-25
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot